332 participants
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-01
- Start Date:
- 2026-02-13
- Completion:
- 2027-09-30
Conditions
- Symptomatic Genetic Dilated Cardiomyopathy
Interventions
- DRUG
No Results Yet